4.7 Article

Phenotypic and Genotypic Characteristics of Inflammatory Bowel Disease in French Canadians: Comparison With a Large North American Repository

期刊

AMERICAN JOURNAL OF GASTROENTEROLOGY
卷 104, 期 9, 页码 2233-2240

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ajg.2009.267

关键词

-

资金

  1. NCRR NIH HHS [5P20RR011126, M01 RR000052, P20 RR011126, UL1 RR024139, RR024139, RR00052, M01 RR000052-370565] Funding Source: Medline
  2. NIDDK NIH HHS [DK062431, U01 DK062422-04, DK062432, U01 DK062422-03, R01 DK064869-06A1, DK072373, U01 DK062422-01, R01 DK076025, U01 DK062422-05, U01 DK062420-07, U01 DK062420-04, R01 DK072373-02, U01 DK062420-02, U01 DK062429-01, U01 DK062422-02, U01 DK062431, R01 DK076025-02, U01 DK062429-07, U01 DK062431-06, U01 DK062422-08S1, R01 DK076025-01A1, DK062422, U01 DK062413, U01 DK062422, U01 DK062422-08, U01 DK062429, U01 DK062431-05, U01 DK062432, DK076025, U01 DK062420-06, U01 DK062420, DK062413, DK062429, U01 DK062420-01, R01 DK072373-03, U01 DK062429-03, DK064869, U01 DK062429-02, U01 DK062431-04, U01 DK062429-04, U01 DK062423-01, R01 DK064869, U01 DK062422-06, U01 DK062420-05, DK062423, U01 DK062431-07, U01 DK062429-05, R01 DK072373-01A1, DK062420, U01 DK062429-08, U01 DK062431-02, U01 DK062431-03, U01 DK062422-07, R01 DK072373, U01 DK062432-08, U01 DK062431-01, U01 DK062423, U01 DK062420-03, U01 DK062429-06] Funding Source: Medline
  3. NIMH NIH HHS [R01 MH057881, MH057881, R37 MH057881] Funding Source: Medline

向作者/读者索取更多资源

OBJECTIVES: Phenotype characteristics of inflammatory bowel disease (IBD) may differ significantly among ethnic subpopulations. The aim of this study was to characterize the IBD phenotype in French Canadians, the most prominent founder population in North America. METHODS: Using well-characterized phenotype data in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-IBD Genetics Consortium repository on patients with IBD, we compared phenotypic characteristics of 202 French Canadians with those of 1,287 other Caucasian patients. These included diagnosis, anatomical location, disease behavior, extraintestinal manifestations, surgical history, and family history of IBD. RESULTS: French-Canadian patients with Crohn's disease (CD) were less likely to have stricturing disease (11 vs. 21 %, P = 0.005; odds ratio (OR): 0.45, 95 % confidence interval (95 % CI): 0.24-0.85). Using a stringent definition of ethnicity (three out of four grandparents being French Canadians, as opposed to self-report, n = 148), French Canadians had a tendency toward developing fistulizing CD (37 vs. 28 %, P = 0.07), and there was an increased prevalence of sacroiliitis among those with IBD (4 vs. 2 %, P = 0.045). Among French Canadians, the numbers of current smokers in CD (40 vs. 25 %, P = 0.006) and former smokers in ulcerative colitis (UC) (35 vs. 20 %, P = 0.03) were significantly higher. The prevalence of one of the three main variants of nucleotide-binding oligomerization domain containing 2 (NOD2) single-nucleotide polymorphisms (SNPs)-among French-Canadian CD patients was 43.2 %. The 3020insC SNP correlated with small bowel disease in French Canadians (75 vs. 0 %, P = 0.006). CONCLUSIONS: French Canadians show an IBD phenotype profile distinct from other Caucasian IBD populations, with an accentuated association between smoking status and IBD. This unique profile may have implications regarding the need for a different approach to the management of IBD in this population.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Gastroenterology & Hepatology

Novel Diagnostic Autoantibodies Against Endothelial Protein C Receptor in Patients With Ulcerative Colitis

Yoichi Kakuta, Tsuyoshi Shirai, Dermot P. B. Mcgovern, Jonathan Braun, Hiroshi Fujii, Atsushi Masamune

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study

Nghia H. Nguyen, Jiyu Luo, Paulina Paul, Jihoon Kim, Gaurav Syal, Christina Ha, Vivek Rudrapatna, Sunhee Park, Nimisha Parekh, Kai Zheng, Jenny S. Sauk, Berkeley Limketkai, Phillip Fleshner, Samuel Eisenstein, Sonia Ramamoorthy, Gil Melmed, Parambir S. Dulai, Brigid S. Boland, Uma Mahadevan, William J. Sandborn, Lucila Ohno-Machado, Dermot McGovern, Siddharth Singh

Summary: Hispanic patients with IBD who are treated with biologic therapy have a higher risk of hospitalization, surgery, and serious infections compared to non-Hispanic patients. Further research is needed to investigate the biological, social, and environmental factors underlying these differences.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature

Phillip Gu, Shishir Dube, Dermot P. B. McGovern

Summary: Alterations in mesenteric adipose tissue play a significant role in Crohn's disease, but their clinical significance is still unclear. Current studies have limitations, but they suggest that mesenteric adipose tissue may serve as a marker for disease severity, surgical risk, and postoperative outcomes. Additionally, it could be a potential target for mitigating postoperative recurrence of Crohn's disease.

INFLAMMATORY BOWEL DISEASES (2023)

Review Gastroenterology & Hepatology

The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients

Julia J. Liu, Bincy P. Abraham, Paula Adamson, Edward L. Barnes, Kelly A. Brister, Oriana M. Damas, Sarah C. Glover, Kimberly Hooks, Ana Ingram, Gilaad G. Kaplan, Edward V. Loftus, Dermot P. B. McGovern, Melodie Narain-Blackwell, Florence-Damilola Odufalu, Sandra Quezada, Vonda Reeves, Bo Shen, Thaddeus S. Stappenbeck, Latonia Ward

Summary: This comprehensive review examines the epidemiology, clinical presentations, disease phenotypes, treatment outcomes, social determinants of health, and genetic and environmental factors in the pathogenesis of IBD in Black and Hispanic patients in the United States. To improve health equity for underserved minorities with IBD, researchers identified priority areas for further investigation.

INFLAMMATORY BOWEL DISEASES (2023)

Article Gastroenterology & Hepatology

The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium

Amanda M. Johnson, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan Galati, Vipul Jairath, Neeraj Narula, Farhad Peerani, Benjamin H. Click, Elliot S. Coburn, ThucNhi Tran Dang, Stephanie Gold, Manasi Agrawal, Rajat Garg, Manik Aggarwal, Danah Mohammad, Brendan Halloran, Gursimran S. Kochhar, Hannah Todorowski, Nabeeha Mohy Ud Din, James Izanec, Amanda Teeple, Chris Gasink, Erik Muser, Zhijie Ding, Arun Swaminath, Komal Lakhani, Dan Hogan, Samit Datta, Ryan C. Ungaro, Brigid S. Boland, Matthew Bohm, Monika Fischer, Sashidhar Sagi, Anita Afzali, Thomas Ullman, Garrett Lawlor, Daniel C. Baumgart, Shannon Chang, David Hudesman, Dana Lukin, Ellen J. Scherl, Jean-Frederic Colombel, Bruce E. Sands, Corey A. Siegel, Miguel Regueiro, William J. Sandborn, David Bruining, Sunanda Kane, Edward V. Loftus, Parambir S. Dulai

Summary: This study evaluated the real-world effectiveness and safety of ustekinumab in patients with Crohn's disease. The results demonstrated that ustekinumab is a safe and effective treatment option for Crohn's disease, especially for biologic-naive patients.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab

Andres J. Yarur, Dermot McGovern, Maria T. Abreu, Adam Cheifetz, Konstantinos Papamichail, Parakkal Deepak, Alexandra Bruss, Poonam Beniwal-Patel, Marla Dubinsky, Stephan R. Targan, Gil Y. Melmed

Summary: This study assessed the relationship between 6-thioguanine nucleotide (6-TGN) levels and the use of oral methotrexate with the pharmacokinetics of biologics. The results showed that higher 6-TGN levels and the use of methotrexate improved the pharmacokinetics of infliximab but did not have the same effect on vedolizumab and ustekinumab. These findings have important implications for clinical treatment.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Inflammatory Bowel Disease and Helicobacter pylori: Protective or Present?

Samuel Tanner, Jeffry Katz, Fabio Cominelli, Miguel Regueiro, Gregory Cooper, Emad Mansoor

Summary: This article examines the prevalence of inflammatory bowel disease in patients with gastritis, duodenitis, and peptic ulcer disease, taking into consideration the presence of Helicobacter pylori infection. It is found that inflammatory bowel disease is less common in patients with H. pylori, and there is no increased risk of developing IBD after undergoing H. pylori eradication therapy.

INFLAMMATORY BOWEL DISEASES (2023)

Article Medicine, Research & Experimental

Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists

Miguel Regueiro, Theresa Hunter, Rina Lukanova, Mingyang Shan, Rosie Wild, Hannah Knight, Priyanka Bannikoppa, April N. Naegeli

Summary: This study assessed the prevalence of fatigue and its association with disease activity and patient-reported outcomes among patients with ulcerative colitis (UC) or Crohn's disease (CD). The results showed that fatigue is a common symptom among patients with UC or CD and is associated with higher disease activity levels and decreased work productivity. Managing fatigue may require a multidisciplinary approach.

ADVANCES IN THERAPY (2023)

Article Gastroenterology & Hepatology

Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial

Yaara Zisman-Ilani, Kimberly D. Thompson, Lori S. Siegel, Todd Mackenzie, Damara J. Crate, Joshua R. Korzenik, Gil Y. Melmed, Patricia Kozuch, Bruce E. Sands, David T. Rubin, Miguel D. Regueiro, Raymond Cross, Douglas C. Wolf, John S. Hanson, Ronald M. Schwartz, Raluca Vrabie, Michael D. Kreines, Timothy Scherer, Marla C. Dubinsky, Corey A. Siegel

Summary: This study aimed to test the impact of shared decision making (SDM) on choice of therapy, decision quality, and provider trust in patients with Crohn's disease. The results showed that patients who received the SDM intervention more frequently chose combination therapy, had lower decisional conflict, and had greater trust in their provider.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Editorial Material Medicine, General & Internal

Hidradenitis suppurativa: Coexistence or dermatological extraintestinal manifestation of Crohn's disease?

Rafael Luis Luporini, Pamela Cristina Bellaz Do Amaral Campos Silva, Miguel Regueiro

FRONTIERS IN MEDICINE (2023)

Article Gastroenterology & Hepatology

HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44D Natural Killer Cells in Ulcerative Colitis

Martin E. Baumdick, Annika Niehrs, Frauke Degenhardt, Maria Schwerk, Ole Hinrichs, Ana Jordan-Paiz, Benedetta Padoan, Lucy H. M. Wegner, Sebastian Schloer, Britta F. Zecher, Jakob Malsy, Vinita R. Joshi, Christin Illig, Jennifer Schroeder-Schwarz, Kimberly J. Moeller, Maureen P. Martin, Yuko Yuki, Mikki Ozawa, Juergen Sauter, Alexander H. Schmidt, Daniel Perez, Anastasios D. Giannou, Mary Carrington, Randall S. Davis, Udo Schumacher, Guido Sauter, Samuel Huber, Victor G. Puelles, Nathaniel Melling, Andre Franke, Marcus Altfeld, Madeleine J. Bunders

Summary: The study identified HLA-DP401 as a risk haplotype and HLA-DP301 as a protective haplotype for UC in European populations. Higher expression of HLA-DP was observed on IECs of individuals with UC compared to controls. Interaction between HLA-DP401 and NKp44 resulted in increased damage to intestinal epithelial cells, while blocking this interaction reduced NK cell-mediated destruction in UC.

GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice

Jill K. J. Gaidos, Badr Al Bawardy, Francis A. Farraye, Miguel Regueiro

Summary: This study investigated the utilization rates of IBD endoscopic scoring systems in clinical practice and associated factors. The study found that the Mayo Endoscopic Subscore (MES) and the Rutgeerts Score were more commonly used, while endoscopic scores for Crohn's disease and pouchitis had lower rates of use. Regular attendance at IBD conferences, higher patient volumes, and incorporation of scoring systems into endoscopy software were associated with increased utilization of these scoring systems.

CROHNS & COLITIS 360 (2023)

Article Multidisciplinary Sciences

Gene-metabolite annotation with shortest reactional distance enhances metabolite genome-wide association studies results

Cantin Baron, Sarah Cherkaoui, Sandra Therrien-Laperriere, Yann Ilboudo, Raphael Poujol, Pamela Mehanna, Melanie E. Garrett, Marilyn J. Telen, Allison E. Ashley-Koch, Pablo Bartolucci, John D. Rioux, Guillaume Lettre, Christine Des Rosiers, Matthieu Ruiz, Julie G. Hussin

Summary: Metabolite genome-wide association studies (mGWAS) have contributed to our understanding of the genetic regulation of metabolite levels. However, interpreting these associations is still challenging due to the lack of tools for annotating gene-metabolite pairs. This study introduces the shortest reactional distance (SRD) metric, based on the comprehensive KEGG database, to improve the biological interpretation of mGWAS results.

ISCIENCE (2023)

Article Genetics & Heredity

Inferring compound heterozygosity from large-scale exome sequencing data

Michael H. Guo, Laurent C. Francioli, Sarah L. Stenton, Julia K. Goodrich, Nicholas A. Watts, Moriel Singer-Berk, Emily Groopman, Philip W. Darnowsky, Matthew Solomonson, Samantha Baxter, Grace Tiao, Benjamin M. Neale, Joel N. Hirschhorn, Heidi L. Rehm, Mark J. Daly, Anne O'Donnell-Luria, Konrad J. Karczewski, Daniel G. MacArthur, Kaitlin E. Samocha

Summary: This study developed a strategy to infer the phase for rare variant pairs within genes using genotypes observed in the Genome Aggregation Database. The approach showed high accuracy in determining phase in both trio data and patients with Mendelian conditions, providing a valuable resource for interpreting rare co-occurring variants in the context of recessive diseases.

NATURE GENETICS (2023)

Article Genetics & Heredity

The role of admixture in the rare variant contribution to inflammatory bowel disease

Courtney Astore, Shivam Sharma, Sini Nagpal, David J. Cutler, John D. Rioux, Judy H. Cho, Dermot P. B. Mcgovern, Steven R. Brant, Subra Kugathasan, I. King Jordan, Greg Gibson

Summary: This study found that rare variants associated with Crohn's disease in Europeans are even rarer in African Americans and mainly contribute to disease risk due to admixture. Additionally, the proportion of European ancestry is correlated with the number of rare CD European variants carried by each African American individual and their polygenic risk of disease.

GENOME MEDICINE (2023)

暂无数据